Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda

Journal of Law, Medicine and Ethics 41 (3):561-570 (2013)
  Copy   BIBTEX

Abstract

The point, for the 946,326th time is that people get elected to office by currying the favor of powerful interest groups. They don’t get elected for their excellence as political philosophers.Congress has consistently failed to solve some serious problems with the cost, effectiveness, and safety of pharmaceuticals. In part, this failure results from the pharmaceutical industry convincing legislators to define policy problems in ways that protect industry profits. By targeting campaign contributions to influential legislators and by providing them with selective information, the industry manages to displace the public’s voice in developing pharmaceutical policy.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,127

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Five Un-Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
Institutional mistrust in the organization of pharmaceutical clinical trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.

Analytics

Added to PP
2016-02-04

Downloads
21 (#762,792)

6 months
10 (#308,815)

Historical graph of downloads
How can I increase my downloads?